Manipal Health Enterprises (MANIPALHOS) — concall transcript

📢 Key Event
Manipal Health Enterprises reported strong Q1 FY27 growth with 38% revenue increase and 26% EBITDA growth, driven by volume expansion and digital initiatives.

🔄 What Changed
Operating margin declined slightly to 24.2% from prior year due to greenfield ramp-up costs, though ex-Sahyadri margins held at 25% and are expected to improve.

🔮 What's Next
The company plans to add approximately 1,000 beds by FY27, including 300 in Q2, with further additions in FY28, and targets a net debt/EBITDA ratio of 0.9x post-IPO repayment.

💡 Investor Takeaway
Shareholders should note that growth is volume-driven and sustainable, with margins expected to expand as new hospitals mature and digital initiatives scale.

Manipal Health Enterprises reported Q1 FY27 revenue of ₹3,091 crores (38% YoY growth) and network EBITDA of ₹749 crores (26% YoY growth), with operating margin at 24.2%. Inpatient volume grew 39% YoY and ALOS improved to 2.7 days. Digital revenue contributed INR 710 crores (23% of total), while Sahyadri added INR 332 crores revenue and INR 58 crores EBITDA. The company added 300 beds in Q2 FY27 across new greenfield hospitals in Electronic City, Raipur, and Nashik, targeting 1,000 beds by FY27. Oncology now contributes 12.2% of revenue with 45% growth, and margins are expected to improve as greenfield facilities mature. Capex guidance stands at INR 2,000 crores this year for 3,000 new beds, with net debt/EBITDA targeted at 0.9x post-IPO.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MANIPALHOS ✨ Ask AI About This

About Manipal Health Enterprises Ltd (MANIPALHOS)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹1,00,297.51 Cr

View full MANIPALHOS stock details →

📡 Get AI alerts when MANIPALHOS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANIPALHOS — Free

💡 Ask AI about this filing

"How will oncology growth impact overall margins in FY27?" "What is the expected EBITDA contribution from the new Whitefield greenfield hospital?" "When will the Raipur and Juhu greenfield hospitals reach EBITDA breakeven?"

Ask AI Free →

📊 More MANIPALHOS filings

See all MANIPALHOS filings →

🔥 Also filed on 30 June 2026

SHIRPUR-G Shirpur Gold Refinery Limited Announcement REFEX Refex Industries Limited Corporate Action ROLLT Rollatainers Limited Announcement SAMMAANCAP Sammaan Capital Limited Corporate Action RUSTOMJEE Keystone Realtors Limited Announcement ZEEMEDIA Zee Media Corporation Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MANIPALHOS files new disclosures

Track MANIPALHOS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANIPALHOS — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd